Clinical Trial Update: FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating FOLFOX6 plus Sir-Spheres microspheres and Avastin for nonresectable liver metastases from colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• FOLFOX6
• SIR-Spheres Microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: Sirtex Medical | Conditions: Colorectal Carcinoma, Liver Metastases | Phase 2, Phase 3 | Status: WITHDRAWN